Emergency uses of the Pfizer-BioNTech COVID-19 Vaccine have not been approved or licensed by FDA, but have been authorized by FDA, under an Emergency Use Authorization (EUA) to prevent Coronavirus Disease 2019 (COVID-19) in individuals 6 months of age and older. The emergency uses are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of the medical product under Section 564(b)(1) of the FD&C Act unless the declaration is terminated or authorization revoked sooner.
Welcome to Pfizer-BioNTech COVID-19 Vaccines Medical Data
-
No cost, No sign-up required
-
Updated with peer-reviewed literature on COVID-19
-
Focus on the Pfizer-BioNTech COVID-19 Vaccine
-
Interactive
-
Key Point summaries to help understand medical data
This site is intended for US Healthcare Professionals. By selecting continue below, you acknowledge and certify that you are a US Healthcare Professional.
Emergency uses of the Pfizer-BioNTech COVID-19 Vaccine have not been approved or licensed by FDA, but have been authorized by FDA, under an Emergency Use Authorization (EUA) to prevent Coronavirus Disease 2019 (COVID-19) in individuals 6 months of age and older. The emergency uses are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of the medical product under Section 564(b)(1) of the FD&C Act unless the declaration is terminated or authorization revoked sooner.